Skip to main content
$1.09 -$0.03 (-2.7%)

04:00 PM EDT on 09/23/22

Amarin Corp plc (ADR) (NASDAQ:AMRN)

CAPS Rating: 4 out of 5

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.

Current Price $1.09 Mkt Cap $439.5M
Open $1.14 P/E Ratio 0.00
Prev. Close $1.09 Div. (Yield) $0.00 (0.0%)
Daily Range $1.04 - $1.14 Volume 5,141,546
52-Wk Range $1.04 - $5.41 Avg. Daily Vol. 3,818,348

Caps

How do you think NASDAQ:AMRN will perform against the market?

Add Stock to CAPS Watchlist

All Players

348 Outperform
29 Underperform
 

All-Star Players

32 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AMRN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TL22 (< 20)
Submitted October 24, 2019

The excellent results of the REDUCE-IT study cannot be overlooked. Sales of Vascepa continue to increase as more Doctors become aware of its benefits. FDA - based on the the REDUCE-IT results, a study which the FDA approved the criteria for - will… More

chris293 (42.54)
Submitted May 07, 2013

FDA approval for fish oil? What else is going on here, are they selling the good parts of the company for what?

Fools bullish on NASDAQ:AMRN are also bullish on:

Fools bearish on NASDAQ:AMRN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AMRN.

Recs

1
Member Avatar TL22 (< 20) Submitted: 10/24/2019 3:02:44 AM : Outperform Start Price: $16.34 NASDAQ:AMRN Score: -115.44

The excellent results of the REDUCE-IT study cannot be overlooked. Sales of Vascepa continue to increase as more Doctors become aware of its benefits. FDA - based on the the REDUCE-IT results, a study which the FDA approved the criteria for - will (little to no doubt) allow an expanded label for Vascepa use towards the end of this year. This will result in an immediate increase in share price, which will continue to increase along with the sale of Vascepa.

Recs

1
Member Avatar XMFRendezvous (97.62) Submitted: 3/4/2019 4:19:13 PM : Outperform Start Price: $21.51 NASDAQ:AMRN Score: -126.41

Buy the (buyout) rumor, sell the news.

High upside.. medium-high risk.

Recs

0
Member Avatar rick16 (< 20) Submitted: 2/22/2019 4:04:09 PM : Outperform Start Price: $19.33 NASDAQ:AMRN Score: -125.28

Great product...no where to go but up.... possible buyout?

Leaderboard

Find the members with the highest scoring picks in AMRN.

Score Leader

vin2066

vin2066 (97.57) Score: +929.25

The Score Leader is the player with the highest score across all their picks in AMRN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Smog79 < 20 6/16/2010 Underperform 3W $2.58 -57.95% +228.18% +286.12 0 Comment
MaxPwr273 74.59 10/26/2011 Underperform 5Y $9.33 -88.37% +195.91% +284.28 0 Comment
HedgeFund007 28.12 12/6/2010 Underperform 1Y $5.50 -80.27% +199.65% +279.92 0 Comment
H8CAGERS < 20 12/1/2011 Underperform 1Y $7.31 -85.16% +194.25% +279.41 0 Comment
Okcfirefighter < 20 12/17/2010 Underperform 5Y $6.72 -83.85% +195.50% +279.36 0 Comment
Luisaespinoza7 46.49 5/18/2012 Underperform 3M $10.34 -89.51% +179.71% +269.22 0 Comment
smoaky 85.15 3/28/2007 Underperform 5Y $21.80 -95.02% +174.01% +269.04 0 Comment
bwlink100 < 20 4/13/2007 Underperform 1Y $29.60 -96.33% +168.13% +264.47 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Lolly131313 88.99 4/19/2007 4/30/2019 Underperform 3Y $37.50 -97.11% +164.17% +261.28 0 Comment
zeccoscott < 20 4/20/2007 Underperform 3W $39.20 -97.23% +162.09% +259.33 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AMRN.